Monthly archive | PharmaTutor

3 April 2026

National Chemical Laboratory looking for Pharmaceutical Sciences candidates

Master / Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences / Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University

3 April 2026

Pharma Fresher Openings in Production, Packing and QC at Ipca Laboratories

Ipca Laboratories is a leading pharmaceutical company across the continents that work on its core values of Quality, Safety, Integrity, Dignity. A consumer-led Global pharmaceutical company, creating healthy doses of life since 1949.

3 April 2026

Openings for Pharmaceutical Sciences candidates at CSIR-NCL

Master / Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University.

3 April 2026

Macleods Walk-In Drive for Freshers in Production, QC & Fermentation

Macleods Pharmaceuticals Limited invites fresh and passionate candidates for Production, QC & Fermentation roles. M.Sc Analytical Chemistry, Microbiology, B.Pharma or M.Pharma graduate.

3 April 2026

Injectable Manufacturing Openings in Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company. Our team of 7,500+ colleagues helps make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of 270+ high- quality medicines.

Looking for candidates with relevant experience in injectable regulated plant as mentioned below

Post : Apprentice Associate / Sr. Assistant / Assistant

3 April 2026

Production, QC, QA, Packing Openings at Ind-Swift Group

Ind-Swift Group, founded in 1986 and headquartered in Chandigarh, India, is a globally trusted pharmaceutical company recognized for its innovation, quality, and commitment to healthcare excellence

3 April 2026

Imfinzi plus Imjudo combined with lenvatinib and transarterial chemoembolisation improves survival in liver cancer

Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab), lenvatinib and transarterial chemoembolisation (TACE) demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of progression-free survival (PFS) versus TACE alone for patients with unresectable hepatocellular carcinoma (HCC) eligible for embolisation.

2 April 2026

Apply Online for Scientific & Medical Writer at Springer Nature

Preference will be given to candidates previously trained and experienced in AdisInsight Drugs / RDI content curation, to at least standard Scientific & Medical Writer and ideally Senior level.

2 April 2026

DCC refers retail pharmacy deregulation proposals to sub-committee, including removal of pharmacist name from licence

In a significant step toward easing the regulatory burden on India's retail pharmacy sector, the Drugs Consultative Committee (DCC) at its 68th meeting on 20 March 2026 directed a sub-committee to examine four landmark deregulation proposals. The sub-committee's findings will be placed before the DCC for final deliberation before any rule amendments are made.